The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
instead of expressing genes that were faithful to the tissue of origin from which they came for example an ovarian cancer cell line should be expressing genes that are expressed in ovarian cancer pancreatic cancer cell lines should be expressing pancreatic genes instead it turned out that there has been a transcriptomic drift that basically all the cell lines irrespective of their tissue of origin express similar genes that make them survivable under adverse in vitro conditions
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.